Safety Committee must meet tomorrow Wed? Well, see
Post# of 148181
If indeed the safety committee meets, the safety committee is required to issue a stop or continue order for the severe/critical trial, I think. We can be very confident the safety committe is not going to halt the severe/critical trial because leronlimab is unsafe. So that leaves either stop the trial because leronlimab is working great or continue the trial because efficacy is not sufficiently established.
But I really don't know